Envarsus Tablet, Extended Release
Product Images NDC 68992-3040

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Envarsus (NDC 68992-3040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Veloxis Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Envarsus 0.75mg 100 Count Bottle Label (Envarsusxr 0pt75mg Bottle 100 Count)

Label for Envarsus XR 0.75 mg extended-release tablets, containing tacrolimus. The label states once-daily oral administration and cautions to swallow the tablet whole without chewing, dividing, or crushing. The package contains 100 tablets and is manufactured for Veloxis Pharmaceuticals, Inc. Storage instructions note controlled room temperature between 15°C and 30°C (59°F–86°F).*

FDA Label Image

Envarsus 0.75mg 30 Count Bottle Label (Envarsusxr 0pt75mg Bottle 30 Count)

Label for Envarsus XR 0.75 mg extended-release oral tablets containing tacrolimus. The label indicates it is a once-daily prescription drug with a 30-tablet count. It includes storage instructions and manufacturer details for Veloxis Pharmaceuticals, Inc.*

FDA Label Image

Envarsus 0.75mg 100 Count Carton Carton (Envarsusxr 0pt75mg Carton 100 Count)

Packaging label for Envarsus XR 0.75 mg extended-release oral tablets containing tacrolimus. The label includes the product name, strength, and quantity of 100 tablets. It lists inactive ingredients and usage instructions. Manufactured by Veloxis Pharmaceuticals, Inc., Cary, North Carolina. The label features barcodes and storage instructions.*

FDA Label Image

Envarsus 0.75mg 30 Count Carton Label (Envarsusxr 0pt75mg Carton 30 Count)

Packaging label for Envarsus XR 0.75 mg extended-release oral tablets containing tacrolimus. The label includes dosage instructions, inactive ingredients, storage conditions, and mentions the use of MeltDose Technology. It is manufactured for Veloxis Pharmaceuticals, Inc, Cary, North Carolina, and the package contains 30 tablets.*

FDA Label Image

Envarsus 1mg 100 Count Bottle Label (Envarsusxr 1mg Bottle 100 Count)

Label for Envarsus XR 1 mg extended-release oral tablets by Veloxis Pharmaceuticals, Inc. The label includes instructions to swallow whole and not to chew, divide, or crush the tablet. The package contains 100 tablets and a barcode is present. Storage instructions and space for expiration and lot numbers are also shown.*

FDA Label Image

Envarsus 1mg 30 Count Bottle Label (Envarsusxr 1mg Bottle 30 Count)

Label of Envarsus XR 1 mg extended-release tablets showing the brand name, active ingredient tacrolimus, dosage form, strength, and quantity of 30 tablets. The label includes dosing instructions to swallow whole and not to chew, divide, or crush. Storage conditions and manufacturer Veloxis Pharmaceuticals, Inc. are also displayed, along with a barcode and placeholders for expiration date and lot number.*

FDA Label Image

Envarsus 1mg 100 Count Carton Label (Envarsusxr 1mg Carton 100 Count)

Packaging label for Envarsus XR 1 mg extended-release tablets containing tacrolimus. The label shows the product name, strength, extended-release form, and quantity of 100 tablets. It includes inactive ingredients and instructions to swallow whole without crushing. The label identifies the labeler as Veloxis Pharmaceuticals, Inc, Cary, North Carolina. Storage instructions and multiple barcodes are visible.*

FDA Label Image

Envarsus 1mg 30 Count Carton Label (Envarsusxr 1mg Carton 30 Count)

Label for Envarsus XR 1 mg extended-release tablets containing tacrolimus. The label shows the brand name, strength, dosage form, and 30 tablets per package. It includes inactive ingredients, manufacturer Veloxis Pharmaceuticals, Inc., storage instructions, and barcodes. The label emphasizes swallowing the tablet whole and indicates 'Rx only.'*

FDA Label Image

Envarsus 4mg 100 Count Bottle Label (Envarsusxr 4mg Bottle 100 Count)

Label for Envarsus XR 4 mg extended-release tablets, containing tacrolimus, from Veloxis Pharmaceuticals, Inc. The label highlights the once-daily oral tablet form with instructions to swallow whole and not to chew, divide, or crush. The packaging contains 100 tablets and includes storage instructions and a barcode.*

FDA Label Image

Envarsus 4mg 30 Count Bottle Label (Envarsusxr 4mg Bottle 30 Count)

Envarsus XR tacrolimus extended-release tablets, 4 mg strength, oral tablet dosage form. The label indicates once-daily dosing, with instructions to swallow the tablet whole without chewing, dividing, or crushing. The package contains 30 tablets and is manufactured by Veloxis Pharmaceuticals, Inc. Storage instructions specify controlled room temperature (25°C with excursions 15°C–30°C). A barcode and spaces for expiration date and lot number are also visible.*

FDA Label Image

Envarsus 4mg 100 Count Carton Label (Envarsusxr 4mg Carton 100 Count)

Packaging label for Envarsus XR 4 mg extended-release oral tablets by Veloxis Pharmaceuticals, Inc. The label indicates a 100-tablet carton containing tacrolimus as the active ingredient. Instructions specify once-daily dosing with the tablet to be swallowed whole, storage conditions at 25°C with permitted excursions, and inclusion of inactive ingredients. The manufacturer is located in Cary, North Carolina.*

FDA Label Image

Envarsus 4mg 30 Count Carton Label (Envarsusxr 4mg Carton 30 Count)

Packaging label for Envarsus XR 4 mg extended-release oral tablets by Veloxis Pharmaceuticals, Inc. The label shows a 30-tablet carton with the NDC 68992-3040-3. It includes dosing instructions for once-daily use, storage conditions, inactive ingredients, and product information such as production with MeltDose Technology.*

FDA Label Image

Chemical-structure (Envarsusxr Figure 1)

Chemical structure diagram of tacrolimus, the active ingredient in Envarsus XR extended-release tablets.*

FDA Label Image

Envarsusxr Figure 3

A box plot chart comparing average tacrolimus trough concentrations (ng/mL) at study visits over time from randomization, for Envarsus XR once daily and tacrolimus capsules twice daily. The chart shows median, interquartile range, whiskers, mean trough concentrations, and target concentration ranges depicted by shaded gray areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.